Trident Texofab Ltd — Important, 10-08-2026: Company Update

Trident Texofab's Board approved the financial results for the quarter ended June 30, 2026. Revenue from Operations was ₹2,614.26 and net profit reached ₹52.18 for the quarter. The company announced the resignation of its Statutory Auditor, M/s. Shah Kailash & Associates LLP, citing increased workload, and will appoint a replacement. M/s. Prit Agrawal & Co. was appointed as the Internal Auditor for FY 2026-27. Additionally, the company forfeited 25% of the amount for 9,11,479 warrants after their conversion period expired, leading to their cancellation. These actions update stakeholders on financial performance, auditing, and share-related developments.